LamassuBiotech
  • Company
    • Mission & History
    • Leadership & Key Collaborators
    • Partners
  • The Lamassu Method
  • Pipeline
    • SA53
    • RABI-767
  • Lamassu Pets
  • Investor Resources
    • Investor Resources
    • Events & Presentations
  • News
    • News Releases
    • Media Coverage
  • Contact Us

Month: April 2026

04/14/2026

Crain’s Cleveland Business: Former FDA leader appointed to Lamassu Biotech board of directors

A former executive at the U.S. Food and Drug Administration has been named to a Cleveland biotech company’s board of directors. Dr. Stephen Hahn, the 24th Commissioner of Food and...
READ THE ARTICLE
04/14/2026

FORMER FDA COMMISSIONER DR. STEPHEN HAHN JOINS LAMASSU BIOTECH BOARD OF DIRECTORS

Hahn will Bring Unparalleled Experience in Drug Development to Growing Biotech Firm (CLEVELAND, OH) – Stephen Hahn, MD, 24th Commissioner of Food and Drugs and the former chief medical executive...
READ THE ARTICLE

Recent Posts

  • CLINICAL TRIAL OF LAMASSU BIOTECH’S SA-53 MDM2 INHIBTOR CONTINUES TO PRODUCE SIGNIFICANT PROGRESS AND FAVORABLE SAFETY PROFILE
  • Crain’s Cleveland Business: Former FDA leader appointed to Lamassu Biotech board of directors
  • FORMER FDA COMMISSIONER DR. STEPHEN HAHN JOINS LAMASSU BIOTECH BOARD OF DIRECTORS
  • Ohio State Launches Clinical Trial for Promising New Treatment for Acute Pancreatitis in Dogs
  • RBV Quarterly: CEO Insights: Dr Gabi Hanna, Lamassu Biotech

Recent Comments

No comments to show.

Archives

  • May 2026
  • April 2026
  • March 2026
  • January 2026
  • November 2025
  • October 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • February 2025
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • April 2021
  • August 2020
  • March 2020

Categories

  • media
  • news
  • Uncategorized

Menu

  • Investor Resources
  • News Releases
  • Contact us

Questions?

1-919-246-3969

info@lamassubio.com

  • Privacy Statement
  • Terms Of Use
  • Accessibility
  • FCOI Policies